Adaptive Biotechnologies Corp
DUS:1HM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Adaptive Biotechnologies Corp
DUS:1HM
|
US |
|
G
|
Geron Corp
F:GON
|
US |
|
Y
|
Yeti Holdings Inc
F:1YN
|
US |
|
T
|
Terracom Ltd
OTC:TERCF
|
AU |
|
Tokyo Metro Co Ltd
F:XO7
|
JP |
|
R
|
Rheinmetall AG
XMUN:RHM
|
DE |
|
Vontier Corp
F:47O
|
US |
|
B
|
Bumi Resources Minerals Tbk PT
XMUN:BUR
|
ID |
Wall St Price Targets
1HM Price Targets Summary
Adaptive Biotechnologies Corp
According to Wall Street analysts, the average 1-year price target for
1HM is 58.783 EUR with a low forecast of 51.108 EUR and a high forecast of 64.939 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1HM's stock price target?
Price Target
58.783
EUR
According to Wall Street analysts, the average 1-year price target for
1HM is 58.783 EUR with a low forecast of 51.108 EUR and a high forecast of 64.939 EUR.
What is the Revenue forecast for Adaptive Biotechnologies Corp?
Projected CAGR
19%
Over the last 7 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 5 years is 19%.
What is the Gross Profit forecast for Adaptive Biotechnologies Corp?
Projected CAGR
19%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 28%. The projected CAGR for the next 5 years is 19%.